About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
A
Pemigatinib in Cholangiocarcinoma: Targeting FGFR2 Fusions
By
Arndt Vogel
7 Videos
1,243 views
May 9, 2023
0 Comments
Login to view comments.
Click here to Login
Featured Video
10:25
Exelixis
Explore the mechanism of Action of a TKI in HCC
Feat.
W. Keiser
Featured Video
20:00
Exelixis
Child-Pugh Classification and its Role in Treatment Decisions in Pat…
Feat.
P. Gholam
Related Content
AUTOPLAY
ON
57:44
Vogl, NY
Vogl,NY on How to Ask Good Questions at Medical Meetings
Feat.
S. Vogl
22:55
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON…
Feat.
R. Kim,
R. Mehta
27:37
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates
Feat.
N. Uboha,
A. Turk,
K. Spencer,
M. Cecchini
27:04
Fengting Yan
Cancer Screening Molecular Tools
06:47
UCSF School of Medicine
Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…
Feat.
H. Kang
17:50
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…
Feat.
G. Sonpavde
13:47
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Tramet…
Feat.
V. Subbiah
16:40
Moffitt Cancer Center
Year in Review: Hepatobiliary Cancers
Feat.
R. Kim,
T. Biachi
07:27
Jason Levy
Opus One: Final Results - RFA in Axial Skeleton
06:03
Total Health
2024 Updates on Targeted Approaches for GI Cancers and New Data in N…
Feat.
A. Grothey
28:25
Integrity Continuing Education
Extensive, Liver-Only Metastases From Colon Cancer: Case Presentatio…
Feat.
V. Lee,
E. Christenson,
N. Bhagat,
E. Winslow
08:24
Yale Cancer Center
GI Oncology Year in Review: Hepatobiliary Cancers
Feat.
P. Kunz
14:54
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "HCC and Cholangiocarcinoma Mini Orals Highl…
Feat.
L. Rimassa
14:33
Insights from 2023 ESMO Annual Meeting
Personalized Medicine and Targeted Agents for Biliary Tract Cancer
Feat.
L. Rimassa
22:33
Integrity Continuing Education
Oligometastatic Colon Cancer to Liver: Case Presentation and Panel D…
Feat.
V. Lee,
R. Kumar,
N. Bhagat,
E. Winslow
09:03
Integrity Continuing Education
Combined Hepatocellular-Cholangiocarcinoma: Diagnosis and Management
Feat.
J. Birkness-Gartman
04:39
Insights from 2024 ASCO® GI Annual Meeting
ASCO® GI 2024 Insights: "PROOF 301 Trial - Oral FGFR Inhibitor …
Feat.
G. Abou-Alfa
29:25
Young Chae
Hyperprogression in Cancer Treated With Immunotherapy
12:21
2023 Johns Hopkins Updates in Gastrointestinal Cancers
Great Debate: Neoadjuvant vs. Adjuvant Therapy for High-Risk BTC - P…
Feat.
M. Yarchoan
21:46
Insights from 2023 ESMO Asia Annual Meeting
ESMO Asia 2023 Insights: "Past, Present & Future Clinical M…
Feat.
M. Ikeda
